SCHEMBL6160982

SCHEMBL6160982

COc1ccc(CN2CCN(c3ccc(Oc4ccccc4)cc3)CC2)c(OC)c1OC

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.70
SMN1; SMN2 Q16637 1/20 0.70
KDM4E B2RXH2 4/20 0.65
MEN1 O00255 8/20 0.64
KMT2A Q03164 8/20 0.64
MAPT P10636 2/20 0.62
ALDH1A1 P00352 3/20 0.58
TSHR P16473 2/20 0.58
CYP1A2 P05177 1/20 0.54
CHRM2 P08172 1/20 0.54
SLC6A4 P31645 1/20 0.54
OPRD1 P41143 1/20 0.54
OPRK1 P41145 1/20 0.54
APOBEC3A P31941 1/20 0.53
CTDSP1 Q9GZU7 1/20 0.53
APOBEC3G Q9HC16 1/20 0.53
HTT P42858 1/20 0.53
ALOX15 P16050 2/20 0.52
HTR7 P34969 1/20 0.51
SMO Q99835 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6162955 0.81 MEN1 (0.59) LMNASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL28298203 0.80 CHRM2 (0.79) LMNASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL18177883 0.79 MEN1 (0.70) LMNASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL6138845 0.79 LMNA (0.70) LMNASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL4754210 0.79 KDM4E (1.00) LMNASMN1; SMN2KDM4EKMT2AMAPT
SCHEMBL6159814 0.78 LMNA (0.88) LMNASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL7758478 0.77 LMNA (0.61) LMNASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL13727299 0.77 LMNA (1.00) LMNASMN1; SMN2KDM4EMEN1KMT2A
Hydrochloric Acid SCHEMBL8637764 0.77 LMNA (0.60) LMNASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL6138709 0.76 LMNA (0.58) LMNASMN1; SMN2KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0755923-B1 Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor DAIICHI SUNTORY PHARMA CO LTD (JP) 2005-05-04 EP disclosed
US-6469010-B1 COMPOSITION ALSO FOR ALLEVIATION OR TREATMENT OF SYMPTOMS DERIVED FROM SEIZURES, EPILEPSY AND MIGRAINE HEADACHES, AND SUPPRESSION OF CALCIUM ION OVERLOAD SUNTORY LIMITED (JP) 2002-10-22 US disclosed
US-6048876-A ANTICONVULSANTS; ANTIEPILEPIC AGENT SUNTORY LIMITED (JP) 2000-04-11 US disclosed
EP-0755923-A1 AMELIORANT OR REMEDY FOR SYMPTOMS CAUSED BY ISCHEMIC DISEASES AND COMPOUNDS USEFUL THEREFOR SUNTORY LIMITED (JP) 1997-01-29 EP disclosed